ARKGvsXHEETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. State Street SPDR S&P Health Care Equipment ETF (XHE) is part of the US Health Care segment. ARKG's top 1 sector exposures are Healthcare. In contrast, XHE's top sector exposures are Healthcare and Finance. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.35% for XHE. ARKG is up 76.72% year-to-date (YTD) with +$90M in YTD flows. XHE performs worse with 5.71% YTD performance, and -$9M in YTD flows. Run a side-by-side ETF comparison of ARKG and XHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs XHE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG XHE | -3.25%+1.69% | +36.71%+6.51% | +76.72%+5.71% | +65.56%+13.97% | +132.21%+39.19% | -29.90%-24.85% |
| Flows | ARKG XHE | +$37M-$40M | +$51M-$10M | +$90M-$9M | +$63M-$12M | -$431M-$223M | -$2.01B-$399M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG XHE | +49.99%+20.36% | +44.59%+22.70% | +44.73%+21.88% | +46.89%+24.86% |
| Max drawdown | ARKG XHE | -17.81%-9.09% | -27.52%-18.20% | -46.41%-24.35% | -76.56%-49.37% |
| Max drawdown duration | ARKG XHE | 22d69d | 126d207d | 882d565d | 1818d1819d |
Trading data
ARKG | XHE | |
Last sale 10/28/2026 at 1:30 PM | $54.82 | $94.04 |
| Previous close 10/27/2026 | $51.65 | $93.25 |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexARKG | XHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
ARKG | XHE | |
|---|---|---|
| Last price | $54.82 | $94.04 |
| 1D performance | +6.14% | +0.85% |
| AuM | $2.18 B | $153.71 M |
| E/R | 0.75% | 0.35% |
Characteristics
ARKG | XHE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | State Street Investment Management |
| Benchmark | - | S&P Health Care Equipment Select Industry Index |
| N° of holdings | 31 | 67 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | January 26, 2011 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
88.62%
Other
11.38%
XHE
USA
93.57%
Other
6.43%
Sectors
ARKG
Healthcare
97.89%
Other
2.11%
XHE
Healthcare
97.47%
Other
2.53%
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
74.64%
XHE
Total weight of top 15 holdings out of 15
30.96%
Top 15 holdings
Data as of August 31, 2026
ARKG
10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.10%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%
XHE
AtriCure, Inc.
2.59%
Strive, Inc. (United States)
2.47%
Inspire Medical Systems, Inc.
2.19%
Glaukos Corp.
2.16%
Butterfly Network, Inc.
2.15%
CONMED Corp.
2.02%
Integer Holdings Corp.
2.02%
Tandem Diabetes Care, Inc.
2.00%
Merit Medical Systems, Inc.
1.99%
Artivion, Inc.
1.94%
Haemonetics Corp.
1.93%
UFP Technologies, Inc.
1.89%
Baxter International, Inc.
1.88%
Becton, Dickinson & Co.
1.87%
Neogen Corp.
1.86%
Frequently asked questions about ARKG and XHE
How have the ARKG and XHE ETFs performed in 2026?
As of October 27, 2026, ARKG is up 76.72% year-to-date (YTD), while XHE has returned 5.71%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or XHE?
Year-to-date, the ARKG ETF saw +$90M in flows, compared to -$9M for XHE.
Which ETF is more volatile: ARKG or XHE?
Over the past year, ARKG had a volatility of 44.59%, while XHE experienced 22.7%.
Which ETF is bigger: ARKG or XHE?
As of October 27, 2026, ARKG holds $2.18 B in assets under management (AUM), while XHE manages $153.71 M.
What sectors do the ARKG and XHE ETFs invest in?
ARKG leans toward sectors like Healthcare. Meanwhile, XHE focuses on Healthcare.
What are the top holdings of the ARKG ETF and XHE ETF?
ARKG top holdings include 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc.. XHE holds in its top three: AtriCure, Inc., Strive, Inc. (United States) and Inspire Medical Systems, Inc..
Which ETF is more diversified: ARKG or XHE?
ARKG holds 31 securities with 74.64% of its assets in the top 15. XHE has 67 securities and a top 15 weight of 30.96%.
Advertisement
Latest news about ARKG & XHE
The Weekly ETF Market Monitor (October 19-23, 2026)
October 26, 2026
ARKG
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
